Last reviewed · How we verify

NCT04082871

Medication Review in Women With Depression and Anxiety

Completed NA Last updated 9 September 2019
What this trial tests

NA trial testing Medication management review in Depression, Anxiety in 73 participants. Completed in 10 January 2017.

Timeline
1 August 2016
Primary endpoint
1 January 2017
10 January 2017

Quick facts

Lead sponsorApplied Science Private University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment73
Start date1 August 2016
Primary completion1 January 2017
Estimated completion10 January 2017

Drugs / interventions tested

Conditions studied

Sponsor

Applied Science Private University

Who can join

Adults 18 to 60, female only, with Depression, Anxiety or Adherence, Patient. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study sought to assess the impact of the MMR service on identifying and resolving TRPs, improving adherence, depression and anxiety scores in females diagnosed with depression and anxiety in Jordan

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Medication review in hospitalised patients to reduce morbidity and mortality.
    Bülow C, Clausen SS, Lundh A, Christensen M. · · 2023 · cited 37× · PMID 36688482 · DOI 10.1002/14651858.cd008986.pub4

Verify or expand the search:

Other recruiting trials for Depression, Anxiety

Currently open trials in the same condition.

Other Applied Science Private University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04082871.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing